Cargando…
Thrombotic risk assessment in 185 WHO-defined essential thrombocythemia patients: single center experience
Thrombosis risk in essential thrombocythemia (ET) patients can be assessed using different prognostic systems. Conventional risk factors include age more than 60 years and history of previous thrombosis. In addition, other factors such as JAK2 V617F mutations, cardiovascular risk factors, leukocytos...
Autores principales: | Dambrauskiene, Ruta, Gerbutavicius, Rolandas, Juozaityte, Elona, Gerbutaviciene, Rima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709397/ https://www.ncbi.nlm.nih.gov/pubmed/26793025 http://dx.doi.org/10.5114/wo.2015.54083 |
Ejemplares similares
-
Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma: A prospective randomised study
por: Rudzianskiene, Milda, et al.
Publicado: (2017) -
Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study
por: Dambrauskienė, R, et al.
Publicado: (2017) -
Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
por: Dambrauskienė, Rūta, et al.
Publicado: (2023) -
Thromboelastographic changes during laparoscopic fundoplication
por: Zostautiene, Indre, et al.
Publicado: (2017) -
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors
por: Mancuso, Salvatrice, et al.
Publicado: (2020)